We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.97%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$4.74B
AUM Growth
-$4.89B
Cap. Flow
-$187M
Cap. Flow %
-3.95%
Top 10 Hldgs %
49.48%
Holding
1,228
New
25
Increased
10
Reduced
14
Closed
23

Top Buys

Rank Stock Value
1
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
+$5.9M
2
SPLK
Splunk Inc
SPLK
+$2.26M
3
COUP
Coupa Software Incorporated
COUP
+$2.15M
4
BKNG icon
Booking.com
BKNG
+$1.8M
5
PPLI
People Inc
PPLI
+$1.64M

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$11.1M
2
Z icon
Zillow
Z
+$3.18M
3
AGN
Allergan plc
AGN
+$2.69M
4
RNG icon
RingCentral
RNG
+$2.07M
5
REXR icon
Rexford Industrial Realty
REXR
+$2.04M

Sector Composition

Rank Sector Weight
1 Real Estate 58.33%
2 Technology 5.66%
3 Healthcare 4.64%
4 Consumer Discretionary 4.34%
5 Communication Services 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QTRX icon
1126
Quanterix
QTRX
$173M
$3K ﹤0.01%
158
– –
VNDA icon
1127
Vanda Pharmaceuticals
VNDA
$314M
$3K ﹤0.01%
301
– –
XBIT icon
1128
XBiotech
XBIT
$68.9M
$3K ﹤0.01%
236
– –
TECX
1129
Tectonic Therapeutic
TECX
$578M
$3K ﹤0.01%
15
– –
TVRD
1130
Tvardi Therapeutics
TVRD
$23.8M
$3K ﹤0.01%
7
– –
PETQ
1131
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$3K ﹤0.01%
136
– –
IMGN
1132
DELISTED
Immunogen Inc
IMGN
$3K ﹤0.01%
845
– –
ATNX
1133
DELISTED
Athenex, Inc. Common Stock
ATNX
$3K ﹤0.01%
22
– –
RDUS
1134
DELISTED
Radius Health, Inc.
RDUS
$3K ﹤0.01%
261
– –
TBIO
1135
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$3K ﹤0.01%
287
– –
PTLA
1136
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3K ﹤0.01%
439
– –
ANAB icon
1137
AnaptysBio
ANAB
$1.59B
$2K ﹤0.01%
172
– –
ASMB icon
1138
Assembly Biosciences
ASMB
$513M
$2K ﹤0.01%
12
– –
BCRX icon
1139
BioCryst Pharmaceuticals
BCRX
$2.43B
$2K ﹤0.01%
869
– –
CRBP icon
1140
Corbus Pharmaceuticals
CRBP
$168M
$2K ﹤0.01%
14
– –
CTMX icon
1141
CytomX Therapeutics
CTMX
$708M
$2K ﹤0.01%
285
– –
DTIL icon
1142
Precision BioSciences
DTIL
$187M
$2K ﹤0.01%
10
– –
MCRB icon
1143
Seres Therapeutics
MCRB
$47M
$2K ﹤0.01%
22
– –
MGNX icon
1144
MacroGenics
MGNX
$254M
$2K ﹤0.01%
310
– –
PBYI icon
1145
Puma Biotechnology
PBYI
$407M
$2K ﹤0.01%
243
– –
SIGA icon
1146
SIGA Technologies
SIGA
$222M
$2K ﹤0.01%
511
– –
SRRK icon
1147
Scholar Rock
SRRK
$5.86B
$2K ﹤0.01%
168
– –
TXMD icon
1148
TherapeuticsMD
TXMD
$24M
$2K ﹤0.01%
31
– –
UBX
1149
DELISTED
Unity Biotechnology
UBX
$2K ﹤0.01%
27
– –
VYGR icon
1150
Voyager Therapeutics
VYGR
$187M
$2K ﹤0.01%
232
– –
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2020 Portfolio in Review

As of Q2 2020, Daiwa Securities Group held 1,228 positions worth $4.74B, down 51% from $9.64B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Daiwa Securities Group withdrew a net $187M in Q2 2020, closing 23 positions and reducing 14 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Daiwa Securities Group opened a new position in Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A worth $6.27M.

  • Daiwa Securities Group's largest Q2 2020 buy was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A: 5,000 shares worth $6.27M.
  • Daiwa Securities Group added most to Splunk Inc in Q2 2020, an estimated $2.26M increase.
  • Daiwa Securities Group's biggest Q2 2020 reduction was Zillow, cutting an estimated $3.18M.
  • Daiwa Securities Group fully exited Berkshire Hathaway Class B in Q2 2020, selling an estimated $11.1M.
  • Daiwa Securities Group's ten largest holdings make up 49% of its $4.74B portfolio in Q2 2020.
  • Daiwa Securities Group opened 25 new positions and closed 23 in Q2 2020.
  • Daiwa Securities Group's portfolio value fell 51% quarter-over-quarter to $4.74B.

Based on Daiwa Securities Group's 13F filing for Q2 2020, filed 11 Aug 2020.